Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML - A strong case for allogeneic stem cell transplantation in first complete remission Editorial

  


Authors: Stahl, M.; Tallman, M. S.
Title: Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML - A strong case for allogeneic stem cell transplantation in first complete remission
Keywords: survival rate; gene mutation; overall survival; allogeneic stem cell transplantation; cancer recurrence; cancer risk; patient selection; note; outcome assessment; cancer incidence; cytogenetics; practice guideline; protein p53; groups by age; high risk patient; cancer regression; myeloablative conditioning; cancer specific survival; therapy effect; real time polymerase chain reaction; karyotype; sample size; chromosome 17p; aml; cd135 antigen; complete remission; midostaurin; disease registry; acute myeloid leukemia; tp53 gene; flt3 gene; human; priority journal; gilteritinib
Journal Title: British Journal of Haematology
Volume: 189
Issue: 5
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-06-01
Start Page: 806
End Page: 808
Language: English
DOI: 10.1111/bjh.16478
PUBMED: 31999852
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079029314&doi=10.1111%2fbjh.16478&partnerID=40&md5=b23d7dd510a8d43b347b78f088b9e22c
Notes: Note -- Export Date: 1 July 2020 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
  2. Maximilian Stahl
    42 Stahl
Related MSK Work